Effects of citicoline on cerebrovascular hemodynamic status in ischemic stroke patients

Effects of citicoline on cerebrovascular hemodynamic status in ischemic stroke patients and comparison with control group

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201705278430N9

Enrollment

Registered

2017-06-21

Start date

2016-08-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke. occlusion and stenosis of cerebral and precerebral arteries, resulting in cerebral infarction

Interventions

Intervention 1: Intervention group : 500 ml Iv citicoline daily for a week. Intervention 2: Control group:Placebo for a week.

Treatment - Drugs

Intervention group : 500 ml Iv citicoline daily for a week

Control group:Placebo for a week

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria :Supratentorial ischemic stroke ; stroke within 24 hours of admission Exclusion criteria:Embolic stroke ; lacunar infarction ;Trombolyticthrapy;Drug sensitivity

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Peak systolic velocity and Mean flow velocit. Timepoint: first and 7th day. Method of measurement: cm / sec by Dopller sonography.	—

Secondary

Measure	Time frame
Increase blood filow. Timepoint: first and 7th day. Method of measurement: Peak systolic velocity and Mean flow velocity by sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRostam Seifaddini

Kerman Medical University

r.seifaddini@gmail.com+98 34331217409

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026